mRNA cancer vaccine shows promise in melanoma trial

Surgical oncologist Dr. John Hingstrom discusses a promising late-stage clinical trial for a personalized mRNA neo-antigen vaccine designed to prevent melanoma recurrence. He explains the science behind the treatment, the timeline for potential availability, and provides essential guidance on skin cancer prevention and the dangers of UV \"tan maxing.\"